Comparative study of purine and pyrimidine nucleoside analogues acting on the thymidylate kinases of Mycobacterium tuberculosis and of humans. - Institut Pasteur Accéder directement au contenu
Article Dans Une Revue ChemBioChem Année : 2003

Comparative study of purine and pyrimidine nucleoside analogues acting on the thymidylate kinases of Mycobacterium tuberculosis and of humans.

Résumé

Thymidine monophosphate kinase (TMPK) from Mycobacterium tuberculosis (TMPKmt) is an attractive target for the design of specific inhibitors. This fact is the result of its key role in the thymidine pathway and of unique structural features in the active site observed by X-ray crystallography, especially in comparison to its human counterpart (TMPKh). Different 5-modified thymidine derivatives, as well as purine and pyrimidine analogues or C-nucleosides were tested on TMPKmt and TMPKh, and the results were rationalized by docking studies. 5-Halogenated 2'-deoxyuridines are the best inhibitors of TMPKmt found and present the highest selectivity indexes in favor of TMPKmt.
Fichier principal
Vignette du fichier
Pochet-Leman.pdf (168.38 Ko) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte
Loading...

Dates et versions

pasteur-00165348 , version 1 (06-08-2007)

Identifiants

Citer

Sylvie Pochet, Laurence Dugué, Gilles Labesse, Muriel Delepierre, Hélène Munier-Lehmann. Comparative study of purine and pyrimidine nucleoside analogues acting on the thymidylate kinases of Mycobacterium tuberculosis and of humans.. ChemBioChem, 2003, 4 (8), pp.742-7. ⟨10.1002/cbic.200300608⟩. ⟨pasteur-00165348⟩
434 Consultations
465 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More